Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$312M Sell
1,096,086
-58,708
-5% -$17.2M 0.3% 58
2023
Q4
$333M Buy
1,154,794
+6,224
+0.5% +$1.7M 0.32% 55
2023
Q3
$309M Sell
1,148,570
-158,594
-12% -$39.6M 0.31% 53
2023
Q2
$290M Sell
1,307,164
-111,883
-8% -$26M 0.29% 60
2023
Q1
$343M Buy
1,419,047
+148,314
+12% +$36.4M 0.35% 49
2022
Q4
$334M Sell
1,270,733
-6,518
-0.5% -$1.75M 0.35% 52
2022
Q3
$288M Sell
1,277,251
-87,168
-6% -$21.1M 0.32% 53
2022
Q2
$332M Sell
1,364,419
-192,328
-12% -$47.1M 0.35% 52
2022
Q1
$376M Buy
1,556,747
+120,407
+8% +$27.7M 0.32% 53
2021
Q4
$323M Buy
1,436,340
+229,849
+19% +$48.5M 0.17% 99
2021
Q3
$257M Sell
1,206,491
-210,934
-15% -$48.5M 0.14% 132
2021
Q2
$345M Buy
1,417,425
+104,691
+8% +$25.8M 0.18% 86
2021
Q1
$327M Sell
1,312,734
-249,880
-16% -$59.6M 0.17% 107
2020
Q4
$359M Buy
1,562,614
+166,762
+12% +$38.4M 0.18% 106
2020
Q3
$355M Sell
1,395,852
-195,003
-12% -$48.3M 0.22% 84
2020
Q2
$375M Buy
1,590,855
+302,210
+23% +$69M 0.27% 69
2020
Q1
$261M Sell
1,288,645
-53,507
-4% -$11.7M 0.23% 83
2019
Q4
$324M Buy
1,342,152
+143,881
+12% +$31.7M 0.23% 66
2019
Q3
$232M Sell
1,198,271
-129,411
-10% -$24.8M 0.2% 85
2019
Q2
$245M Sell
1,327,682
-16,139
-1% -$2.89M 0.22% 80
2019
Q1
$255M Buy
1,343,821
+13,954
+1% +$2.66M 0.23% 68
2018
Q4
$259M Buy
1,329,867
+3,652
+0.3% +$712K 0.27% 65
2018
Q3
$275M Buy
1,326,215
+49,518
+4% +$9.76M 0.25% 58
2018
Q2
$236M Sell
1,276,697
-492,481
-28% -$87.1M 0.23% 65
2018
Q1
$302M Buy
1,769,178
+289,173
+20% +$53.1M 0.28% 52
2017
Q4
$257M Sell
1,480,005
-76,258
-5% -$13.5M 0.23% 76
2017
Q3
$290M Sell
1,556,263
-126,110
-7% -$22.3M 0.28% 59
2017
Q2
$290M Sell
1,682,373
-159,259
-9% -$25.9M 0.28% 63
2017
Q1
$302M Sell
1,841,632
-18,951
-1% -$3.15M 0.27% 61
2016
Q4
$272M Sell
1,860,583
-305,369
-14% -$46M 0.27% 59
2016
Q3
$361M Buy
2,165,952
+234,710
+12% +$39.7M 0.34% 43
2016
Q2
$294M Buy
1,931,242
+104,479
+6% +$16.2M 0.33% 49
2016
Q1
$274M Buy
1,826,763
+9,817
+0.5% +$1.46M 0.33% 55
2015
Q4
$295M Buy
1,816,946
+120,083
+7% +$18.9M 0.34% 49
2015
Q3
$235M Sell
1,696,863
-485,523
-22% -$76.5M 0.28% 65
2015
Q2
$335M Buy
2,182,386
+215,258
+11% +$34.5M 0.33% 48
2015
Q1
$314M Sell
1,967,128
-172,919
-8% -$27.2M 0.32% 56
2014
Q4
$341M Sell
2,140,047
-2,773,699
-56% -$432M 0.3% 57
2014
Q3
$690M Buy
4,913,746
+3,254,135
+196% +$425M 0.56% 21
2014
Q2
$196M Sell
1,659,611
-159,378
-9% -$18.4M 0.16% 114
2014
Q1
$224M Sell
1,818,989
-295,170
-14% -$35.8M 0.22% 84
2013
Q4
$241M Buy
2,114,159
+387,427
+22% +$44.1M 0.22% 79
2013
Q3
$193M Sell
1,726,732
-247,298
-13% -$26.8M 0.19% 90
2013
Q2
$195M Buy
+1,974,030
New +$205M 0.2% 81

Other funds holding AMGN

Credit Suisse's AMGN Position: Q1 2024 in Review

Credit Suisse reduced its Amgen (AMGN) stake by 5.1% in Q1 2024, selling an estimated $17.2M and leaving 1,096,086 shares worth $312M. The position accounts for 0.3% of the portfolio, ranked #58.

Credit Suisse first reported a position in AMGN in Q2 2013 and has held it in 44 quarters since. The position peaked at $690M in Q3 2014. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Credit Suisse held 1,096,086 shares of Amgen worth $312M as of Q1 2024.
  • Credit Suisse sold 58,708 Amgen shares in Q1 2024, an estimated $17.2M.
  • Amgen made up 0.3% of Credit Suisse's portfolio in Q1 2024, its #58 holding.
  • Credit Suisse first reported a position in Amgen in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Amgen position peaked at $690M in Q3 2014.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.